MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    mGlu3 receptors in Parkinson’s disease as a candidate target for neuroprotective therapy: evidence from preclinical studies to human genetic.

    M. Alborghetti, L. Di Menna, V. Bruno, G. Battaglia, FE. Pontieri, E. Bianchini, M. Simmaco, M. Borro, F. Nicoletti (Rome, Italy)

    Objective: In a  toxicological model of mouse parkinsonism through chronic injection of MPTP, we examined whether the presence or absence of mGlu3 receptors affected neurodegeneration…
  • 2022 International Congress

    Spinal cord stimulation for gait problems in Parkinson´s disease: Long term report and placebo viability

    R. Carra, J. Menezes, T. Capato, K. Duarte, R. Cury (Sao Paulo, Brazil)

    Objective: In the present study we set out to report a very long-term follow-up period of spinal cord stimulation (SCS) for Parkinson's Disease (PD) patients…
  • 2022 International Congress

    Assessment of the long-term effects of STN-DBS on axial symptoms in PD patients through a standardized clinical-instrumental approach

    F. Cavallieri, I. Campanini, A. Gessani, V. Fioravanti, B. Damiano, S. Scaltriti, E. Bardi, M. Corni, F. Antonelli, V. Rispoli, G. Di Rauso, F. Cavalleri, M. Molinari, S. Contardi, E. Menozzi, S. Meletti, G. Biagini, E. Moro, C. Budriesi, A. Merlo, F. Valzania (Reggio Emilia, Italy)

    Objective: To evaluate the long-term effects of bilateral STN-DBS and levodopa on axial symptoms in PD patients and the possible correlations between speech and gait…
  • 2022 International Congress

    Dopamine neuron platform for screening molecular mechanisms and inhibitory drugs against alpha-synuclein aggregation

    S. Er, I. Hlushchuk, P. Chmielarz, A. Domanskyi, M. Airavaara (Helsinki, Finland)

    Objective: Optimization of a dopamine neuron based,in vitro platform is beneficial for studying molecular mechanisms of alpha-synuclein aggregation,and screening of inhibitory drugs and deducing their…
  • 2022 International Congress

    The reliability and validity of the Ziegler test for measuring freezing of gait in people with Parkinson’s disease.

    L. Goh, S. Paul, C. Canning, K. Ehgoetz Martens, J. Song, S. Campoy, N. Allen (Camperdown, Australia)

    Objective: To determine the inter-rater and test-retest reliability of the Ziegler test to measure freezing of gait (FOG) severity in people with Parkinson’s disease (PwPD).…
  • 2022 International Congress

    GPi-DBS induced brain metabolic activation in cervical dystonia

    EA. Honkanen, J. Korpela, E. Pekkonen, J. Aaltonen, M. Koivu, O. Eskola, H. Eldebakey, J. Volkmann, V. Kaasinen, MM. Reich, J. Joutsa (Turku, Finland)

    Objective: To investigate the effects of GPi-DBS on brain glucose metabolism locally at the stimulation site and across the whole brain in patients with cervical…
  • 2022 International Congress

    Relationship between cholinergic basal forebrain volume and short-latency sensory afferent inhibition in Parkinson’s disease with varying degrees of cognitive performance

    JF. Martín-Rodríguez, P. Franco Rosado, E. Iglesias Camacho, AM. Castellano-Gerrero, MA. Labrador-Espinosa, B. Villarreal, L. Muñoz-Delgado, D. Macías-García, P. álvarez Toledo, M. San Eufrasio, M. Reina Castillo, S. Jesús, A. Adarmes-Gómez, F. Carrillo, MJ. Grothe, P. Mir (Sevilla, Spain)

    Objective: To assess the relationship between volumetric measures of cholinergic basal forebrain (CBF) degeneration and short-latency sensory afferent inhibition (SAI) in Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    Electrical stimulation of muscle afferents for tremor reduction in essential tremor patients

    M. González Sánchez, JR. Pérez Sánchez, A. Pascual Valdunciel, F. Oliveira Barroso, S. Muceli, B. Adán-Barrientos, V. Escobar-Segura, M. Ki Jung, A. Muñoz González, A. Schneider, KP. Hoffmann, D. Farina, JL. Pons, FJ. Grandas Pérez (Madrid, Spain)

    Objective: To describe the preliminary clinical results of a research project on electrical stimulation of muscle afferents to reduce tremor in patients with Essential Tremor…
  • 2022 International Congress

    Impact of DBS on cognitive functions in Parkinson’s disease in 1 year follow-up

    A. Martinkovičová, Z. Košutzká, M. Pápayová, I. Straka, M. Kľoc, P. Valkovič (Bratislava, Slovakia)

    Objective: The aim of our study was to compare performance in neuropsychology tests in patients with Parkinson’s disease (PD) with implanted electrodes of Deep Brain…
  • 2022 International Congress

    Genetic landscape of dystonia in Asian Indian patients

    R. Rajan, A. Saini, R. Mewara, B. Verma, D. Radhakrishnan, E. Arunmozhimaran, A. Gupta, V. Vishnu, M. Singh, R. Bhatia, R. Mir, I. Singh, F. Mohammed, B. Binukumar, V. Scaria, A. Srivastava, P. Srivastava (New Delhi, India)

    Objective: To identify potentially pathogenic genomic variations associated with dystonia phenotypes in Asian Indian patients with dystonia. Background: The Asian Indian population is underrepresented in…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley